{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:28:27Z","timestamp":1778851707785,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0547-9","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T02:39:11Z","timestamp":1448332751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis"],"prefix":"10.1186","volume":"10","author":[{"given":"Maurice C.","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes M.","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrie E.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanda H.","family":"Schieving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik J.","family":"van Lindert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes H.","family":"Kaanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert O.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"547_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"A Gajjar","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7:813\u201320.","journal-title":"Lancet Oncol"},{"key":"547_CR2","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","volume":"24","author":"RJ Packer","year":"2006","unstructured":"Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202\u20138.","journal-title":"J Clin Oncol"},{"key":"547_CR3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ejca.2006.01.039","volume":"42","author":"BL Pizer","year":"2006","unstructured":"Pizer BL, Weston CL, Robinson KJ, Ellison DW, Ironside J, Saran F, et al. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP\/UKCCSG PNET 3 study. Eur J Cancer. 2006;42:1120\u20138.","journal-title":"Eur J Cancer"},{"key":"547_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2004-822626","volume":"216","author":"G Calaminus","year":"2004","unstructured":"Calaminus G, Bamberg M, J\u00fcrgens H, Kortmann RD, S\u00f6rensen N, Wiestler OD, et al. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: Results of the German Cooperative trial MAKEI 89. Klin Padiatr. 2004;216:141\u20139.","journal-title":"Klin Padiatr"},{"issue":"23","key":"547_CR5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1200\/JCO.2005.05.187","volume":"1","author":"TM Tekautz","year":"2005","unstructured":"Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, et al. Atypical teratoid\/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol. 2005;1(23):1491\u20139.","journal-title":"J Clin Oncol"},{"issue":"71","key":"547_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2007.09.037","volume":"1","author":"TE Merchant","year":"2008","unstructured":"Merchant TE, Boop FA, Kun LE, Sanford RA. A retrospective study of surgery and reirradiation for recurrent ependymoma. Int J Radiat Oncol Biol Phys. 2008;1(71):87\u201397.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"547_CR7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/neuonc\/not151","volume":"15","author":"QT Ostrom","year":"2013","unstructured":"Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010. Neuro Oncol. 2013;15:646\u20137.","journal-title":"Neuro Oncol"},{"key":"547_CR8","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/1097-0142(20011215)92:12<3155::AID-CNCR10158>3.0.CO;2-C","volume":"92","author":"P Kaatsch","year":"2001","unstructured":"Kaatsch P, Rickert CH, K\u00fchl J, Sch\u00fcz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer. 2001;92:3155\u201364.","journal-title":"Cancer"},{"issue":"3","key":"547_CR9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","volume":"17","author":"PM Zeltzer","year":"1999","unstructured":"Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children\u2019s Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17(3):832\u201345.","journal-title":"J Clin Oncol"},{"key":"547_CR10","unstructured":"Children\u2019s Oncology Group COG-ACNS-0332 trial (NCT00392327): Efficacy of carboplatin administered concomitantly with radiation and isoretinoin as a pro-apoptotic agent in other than average risk medulloblastoma\/PNET patients. A groupwide phase III study."},{"key":"547_CR11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0360-3016(89)90080-1","volume":"17","author":"M Tatcher","year":"1989","unstructured":"Tatcher M, Glicksman A. Field matching considerations in craniospinal irradiation. Int J Radiat Oncol Biol Phys. 1989;17:865\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"547_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2005.11.009","volume":"78","author":"WA Parker","year":"2006","unstructured":"Parker WA, Freeman CR. A simple technique for craniospinal radiotherapy in the supine position. Radiother Oncol. 2006;78:217\u201322.","journal-title":"Radiother Oncol"},{"key":"547_CR13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0360-3016(01)02717-1","volume":"52","author":"EL Chang","year":"2002","unstructured":"Chang EL, Allen P, Wu C, Ater J, Kuttesch J, Maor MH. Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M.D. Anderson Cancer Center. Int J Rad Biol Phys. 2002;52:1008\u201316.","journal-title":"Int J Rad Biol Phys"},{"key":"547_CR14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0360-3016(03)01574-8","volume":"58","author":"WH St Clair","year":"2004","unstructured":"St Clair WH, Adams JA, Bues M, Fullerton BC, La Shell S, Kooy HM, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Biol Phys. 2004;58:727\u201334.","journal-title":"Int J Radiat Biol Phys"},{"key":"547_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1748-717X-7-116","volume":"7","author":"RM Howell","year":"2012","unstructured":"Howell RM, Giebeler A, Koontz-Raisig W, Mahajan A, Etzel CJ, D\u2019Amelio Jr AM, et al. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol. 2012;7:116.","journal-title":"Radiat Oncol"},{"key":"547_CR16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijrobp.2007.04.052","volume":"69","author":"W Parker","year":"2007","unstructured":"Parker W, Filion E, Roberge D, Freeman CR. Intensity-modulated radiotherapy for craniospinal irradiation: Target volume considerations, dose constraints, and competing risks. Int J Rad Biol Phys. 2007;69:251\u20137.","journal-title":"Int J Rad Biol Phys"},{"key":"547_CR17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ijrobp.2007.02.037","volume":"68","author":"A Pai Panandiker","year":"2007","unstructured":"Pai Panandiker A, Ning H, Likhacheva A, Ullman K, Arora B, Ondos J, et al. Craniospinal irradiation with spinal IMRT to improve target homogeneity. Int J Radiat Oncol Biol Phys. 2007;68:1402\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"547_CR18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2010.07.1987","volume":"81","author":"JM Kusters","year":"2011","unstructured":"Kusters JM, Louwe RJ, van Kollenburg PG, Kunze-Busch MC, Gidding CE, van Lindert EJ, et al. Optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction. Int J Radiat Oncol Biol Phys. 2011;81:1405\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"547_CR19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12094-013-1048-7","volume":"16","author":"JL Lopez Guerra","year":"2014","unstructured":"Lopez Guerra JL, Marrone I, Jaen J, Bruna M, Sole C, Sanchez-Reyes A, et al. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma. Clin Transl Oncol. 2014;16:96\u2013101.","journal-title":"Clin Transl Oncol"},{"key":"547_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-8140(98)00024-3","volume":"48","author":"S Jefferies","year":"1998","unstructured":"Jefferies S, Rajan B, Ashley S, Traish D, Brada M. Haematological toxicity of cranio-spinal irradiation. Radiother Oncol. 1998;48:23\u20137.","journal-title":"Radiother Oncol"},{"key":"547_CR21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/pbc.22215","volume":"54","author":"F Huang","year":"2010","unstructured":"Huang F, Parker W, Freeman CR. Feasibility and early outcomes of supine-position craniospinal irradiation. Pediatr Blood Cancer. 2010;54:322\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"547_CR22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pbc.24554","volume":"60","author":"G Suneja","year":"2013","unstructured":"Suneja G, Poorvu PD, Hill-Kayser C, Lustig RA. Acute toxicity of proton beam radiation for pediatric central nervous system malignancies. Pediatr Blood Cancer. 2013;60:1431\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"547_CR23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","volume":"46","author":"RD Kortmann","year":"2000","unstructured":"Kortmann RD, K\u00fchl J, Timmermann B, Mittler U, Urban C, Budach V, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT\u201991. Int J Radiat Oncol Biol Phys. 2000;46:269\u201379.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"547_CR24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3171\/jns.1994.81.5.0690","volume":"81","author":"RJ Packer","year":"1994","unstructured":"Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg. 1994;81:690\u20138.","journal-title":"J Neurosurg"},{"key":"547_CR25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0360-3016(80)90175-3","volume":"6","author":"GE Sheline","year":"1980","unstructured":"Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980;6:1215\u201328.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 5","key":"547_CR26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"F Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conference. Ann Oncol. 2010;21 Suppl 5:232\u201343.","journal-title":"Ann Oncol"},{"key":"547_CR27","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1200\/JCO.2005.04.4685","volume":"24","author":"RK Wong","year":"2006","unstructured":"Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, et al. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: A placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). J Clin Oncol. 2006;24:3458\u201364.","journal-title":"J Clin Oncol"},{"key":"547_CR28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF03259853","volume":"1","author":"SS Legha","year":"1986","unstructured":"Legha SS. Vincristine neurotoxicity: Pathophysiology and management. Med Toxicol. 1986;1:421\u20137.","journal-title":"Med Toxicol"},{"key":"547_CR29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.1998.16.2.754","volume":"16","author":"EA Perez","year":"1998","unstructured":"Perez EA, Hesketh P, Sandbach J, Reeves J, Chawla S, Markman M, et al. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: A multicenter, double-blind, randomized parallel study. J Clin Oncol. 1998;16:754\u201360.","journal-title":"J Clin Oncol"},{"key":"547_CR30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.bjc.6602754","volume":"93","author":"WP Levin","year":"2005","unstructured":"Levin WP, Kooy H, Loeffler JS, DeLaney TF. Proton beam therapy. Br J Cancer. 2005;93:849\u201354.","journal-title":"Br J Cancer"},{"key":"547_CR31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2004.04.031","volume":"60","author":"BD Lawenda","year":"2004","unstructured":"Lawenda BD, Gagne HM, Gierga DP, Niemierko A, Wong WM, Tarbell NJ, et al. Permanent alopecia after cranial irradiation: Dose-response relationship. Int J Radiat Oncol Biol Phys. 2004;60:879\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"547_CR32","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2003.05.116","volume":"21","author":"RE Taylor","year":"2003","unstructured":"Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology\/United Kingdom Children\u2019s Cancer Study Group PNET-3 Study. J Clin Oncol. 2003;21:1581\u201391.","journal-title":"J Clin Oncol"},{"key":"547_CR33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00000421-200302000-00012","volume":"26","author":"AC Paulino","year":"2003","unstructured":"Paulino AC, Wen BC, Mayr NA, Tannous R, Loew TW, Goldman FD, et al. Protracted radiotherapy treatment duration in medulloblastoma. Am J Clin Oncol. 2003;26:55\u20139.","journal-title":"Am J Clin Oncol"},{"key":"547_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/neuonc\/nos267","volume":"15","author":"RJ Packer","year":"2013","unstructured":"Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: Results of Children\u2019s Oncology Group trial A9961. Neuro Oncol. 2013;15:97\u2013103.","journal-title":"Neuro Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0547-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:55:33Z","timestamp":1718211333000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ro-journal.com\/content\/10\/1\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["547"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0547-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]},"article-number":"241"}}